NEW YORK/GENEVA – 31 December 2012 - Médecins Sans Frontières (MSF) welcomed the approval by the US Food and Drug Administration of bedaquiline, the first new drug active against tuberculosis (TB) to be registered since 1963.

A joint Union/MSF publication providing transparent information on prices and quality-assured sources for DR-TB medicines, as well as a summary of the challenges still limiting their access to a broader number of patients.